MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Northwest Biotherapeutics Company Profile (NASDAQ:NWBO)

Consensus Ratings for Northwest Biotherapeutics (NASDAQ:NWBO) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Northwest Biotherapeutics (NASDAQ:NWBO)
Show:
DateFirmActionRatingPrice TargetActions
3/12/2014OppenheimerDowngradeOutperform -> Market Perform$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2014Summer StreetBoost Price TargetBuy$10.33 -> $15.10View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/16/2013OppenheimerInitiated CoverageNeutral -> Outperform$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/19/2013Summer StreetInitiated CoverageBuy$10.33View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2013 forward)